The Department of Health and Human Services is issuing a funding opportunity through the National Institute for Occupational Safety and Health (NIOSH) for exploratory and developmental research grants related to World Trade Center (WTC) survivors, under the James Zadroga 9/11 Health and Compensation Act. The focus is on addressing diagnostic and treatment uncertainties for individuals affected by the September 11, 2001 terrorist attacks. Eligible institutions can submit multiple distinct applications, with an emphasis on research that benefits at-risk populations, especially those who are minorities or vulnerable due to age or health conditions. Key research interests include examining both physical and mental health conditions, improving healthcare and wellbeing, and understanding long-term health effects. The funding amounts to an estimated total of $4 million, supporting 4 to 8 grants, each up to $500,000 over two years. Applications are subject to strict deadline requirements and must conform to specific instructions, with the first round due on December 5, 2023. This initiative aims to enhance knowledge regarding health impacts while contributing to national public health objectives.
The World Trade Center (WTC) Health Program has released a Notice of Funding Opportunity (NOFO) identified as RFA-OH-24-003, specifically aimed at survivors, including youth impacted by the WTC disaster. It notably excludes proposals involving responders. This designation contrasts with RFA-OH-24-002, which accommodates both responders and survivors as study populations and focuses on Lifestyle Medicine. Both R21 NOFOs have a maximum performance period of two years, with total funding up to $500,000, allowing a maximum of $365,000 in any single year. Additionally, the FY2024 U01 applications also permit a two-year performance period and an annual budget capped at $350,000. For K01 applications, the timeframe extends to three years, with financial provisions including $100,000 per year for salary and fringe benefits and $60,000 per year for research development costs. The document directs applicants to Part 2, Section II for comprehensive details regarding these funding opportunities and their requirements.